Updated overall survival and safety profile of durvalumab monotherapy in advanced NSCLC Meeting Abstract
| Authors: | Hellmann, M. D.; Antonia, S. J.; Balmanoukian, A. S.; Brahmer, J. R.; Ou, S. H. I.; Kim, S. W.; Ahn, M. J.; Kim, D. W.; Gutierrez, M.; Liu, S. V.; Schoffski, P.; Jaeger, D.; Jamal, R.; Leach, J. W.; Jerusalem, G. H. M.; Lutzky, J.; Nemunaitis, J. J.; Gu, Y.; Abdullah, S. E.; Segal, N. H. |
| Abstract Title: | Updated overall survival and safety profile of durvalumab monotherapy in advanced NSCLC |
| Meeting Title: | 2018 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2018 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-10 |
| Language: | English |
| ACCESSION: | WOS:000436177700161 |
| DOI: | 10.1200/JCO.2018.36.5_suppl.169 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 169 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
